The COVID-19 Saliva Screening Test Potential Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The potential market for the COVID-19 saliva screening test has seen substantial growth previously. The market size is expected to increase from $3.9 billion in 2024 to $4.29 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.9%.
The market size for the COVID-19 saliva screening test potential is forecasted to reach $6.17 billion in 2029 with a compound annual growth rate of 9.5%.
Download Your Free Sample of the 2025 COVID-19 Saliva Screening Test Potential Market Report and Uncover Key Trends Now!The drivers in the covid-19 saliva screening test potential market are:
• Increased potential for home testing
• Unprecedented need for diagnostic testing due to the pandemic
• Rise in public awareness about COVId-19 testing methods
• Investment in research and development activities
The COVID-19 saliva screening test potential market covered in this report is segmented –
1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing, Decentralized Testing
The trends in the covid-19 saliva screening test potential market are:
• Increasing adoption of COVId-19 saliva tests in non-healthcare settings is a significant upcoming trend.
• Integration of saliva tests with digital health platforms is increasingly shaping the future.
• The emergence of next-generation technologies is significantly influencing the market.
• Strategic partnerships are a growing trend in this market.
The major players in the covid-19 saliva screening test potential market are:
• Roche Diagnostics Corporation
• Thermo Fisher Scientific Inc
North America was the largest region in the COVID-19 saliva screening test potential market in 2023